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PURPOSE. To evaluate the role of rbt genes downstream of
Tup1p, a transcription factor regulating fungal filamentation, in
experimental Candida albicans keratitis.
METHODS. Corneas of BALB/c mice were scarified and topically
inoculated with 105 or 106 colony-forming units (CFU) of a
wild-type human isolate of C. albicans (SC5314), a mutant
strain with a transposon-induced homozygous disruption of
the rbt1 gene (Tn7-rbt1), its control (DAY286), homozygous
rbt knockout mutants deficient in rbt1 (BCa7-4) or rbt4
(BCa11-3), or their parental control (CAF2-1). Eyes were scored
daily for clinical severity of fungal keratitis and were examined
histopathologically.
RESULTS. With a 105 CFU inoculum, the CAF2-1 control and its
mutant derivatives (BCa7-4 and BCa11-3) produced signifi-
cantly lower keratitis scores than did the moderately severe
keratitis induced by control strains SC5314 and DAY286 and
the Tn7-rbt1 mutant (P  0.05). At a 106 CFU inoculum, all
strains induced severe disease except for the rbt4-deficient
mutant. Fungal keratitis caused by Tn7-rbt1 was as severe as
that of control strains (P  0.2), and the BCa7-4 mutant initially
caused severe disease that gradually waned (P  0.02). How-
ever, the BCa11-3 mutant produced moderate disease that was
significantly less severe than that induced by control strains
(P  0.04) and resolved within 1 week.
CONCLUSIONS. The rbt4 gene of C. albicans is a potential viru-
lence factor in posttraumatic corneal infection. Genetically
regulated hyphal morphogenesis appears to be involved in the
initial pathogenesis of experimental keratomycosis. (Invest
Ophthalmol Vis Sci. 2007;48:2535–2539) DOI:10.1167/
iovs.06-0909
The yeast Candida albicans is a normal commensal and apathogenic opportunist. Virulence factors of C. albicans
infection include adhesion to host cells,1 secretion of en-
zymes,2 and phenotypic transformation from yeasts to hy-
phae.3–5 A gene controlling the morphogenic switch to hyphal
forms encodes a transcription factor involved in repression of
filamentous growth, identified through sequence identity with
the Saccharomyces cerevisiae tup1 gene.6 Deletion of tup1 in
C. albicans results in constitutive growth of pseudohyphae
that do not injure or invade host cells.6,7
Genes downstream of tup1 are designated rbt (repressed by
Tup1p).8 The rbt1 gene encodes a cell-wall protein involved in
fungal adherence, and the rbt4 gene codes for a hyphally
expressed protein.9,10 Mutations in these rbt genes attenuate
the severity of systemic candidiasis in experimental animals.8
Braun et al.8 also suggested a role for rbt genes in fungal
keratitis using a rabbit model. We evaluated these genes as
potential virulence factors in a murine model of posttraumatic
keratomycosis.11
We examined disease severity induced by various C. albi-
cans yeast strains, including a wild-type strain (SC5314), a
homozygous mutant in the rbt1 gene from a transposon-gen-
erated mutant library (Tn7-rbt1),12 its parental control
(DAY286), a homozygous rbt1 knockout (BCa7-4), a homozy-
gous rbt4 knockout (BCa11-3), and their parental control
(CAF2-1).8 Using an in vivo model that offers quantifiable
assessment of fungal keratitis, our results indicate that the rbt4




The C. albicans yeast strains used in this study include SC5314,
DAY286, Tn7-rbt1, CAF2-1, BCa7-4, and BCa11-3 (Table 1). SC5314 is
a wild-type, virulent C. albicans strain isolated from a human.13
DAY286 is the parental control for the Tn7-rbt1 (rbt1/) mutant.12
CAF2-1 is the parental control strain14 used to generate the BCa7-4
(rbt1/) and BCa11-3 (rbt4/) knockout mutant strains.8 C. albicans
strains were routinely grown on YPD (1% yeast extract, 2% peptone-
tryptone, and 2% dextrose) medium at 30°C. The yeasts were har-
vested for inocula in their exponential growth phase and diluted with
sterile phosphate-buffered saline (PBS).
In Vitro Growth Kinetics
Proliferation kinetics for each strain was measured in either YPD
medium or SD medium (0.67% Difco yeast nitrogen base without
amino acids and 2% dextrose; Difco, Detroit, MI) lacking uracil sup-
plementation (SD-ura) at 33°C. Cultures were incubated at 33°C to
mimic the temperature of the cornea. Each C. albicans strain was
grown overnight in 5 mL of either YPD or SD-ura liquid medium. The
concentration was estimated by using a spectrophotometer to measure
the optical density (OD) at a wavelength of 600 nm and a conversion
factor of one OD600 unit equivalent to 3  10
7 colony-forming units
(CFU)/mL.11 Three cultures were analyzed for each yeast strain. For
growth in YPD, 103 CFU of yeast was added to 5 mL YPD liquid
medium and incubated at 33°C with continuous shaking for 2 days. For
growth in SD-ura, 105 CFU was added to 5 mL SD-ura medium and
incubated at 33°C with continuous shaking for 2 days. Concentrations
were measured during the exponential phase of growth at 9, 24, 32,
and 48 hours after inoculation (PI). Doubling times for each culture
were calculated from the plotted data, and the mean for each strain
was reported. Statistical analyses of the results are based on Student’s
t-test.
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Animals
Immunocompetent adult female BALB/c mice (Harlan Sprague-Dawley,
Houston, TX) 6 to 8 weeks old were anesthetized, and their corneas
superficially scarified as described previously.11 The scarified cornea
received a 5-L inoculum of each C. albicans yeast strain that totaled
either 105 or 106 CFU or 5 L of sterile PBS for the negative control.
Animals were treated in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research, and the research
protocol was approved by the Baylor College of Medicine Institutional
Animal Care and Use Committee.
Clinical Scoring
Mice were monitored daily for up to 8 days PI and were scored for
disease severity with the aid of a dissecting microscope.11 The same
investigator estimated keratitis severity scores daily throughout 8 days
of follow-up without consideration of experimental group, using writ-
ten descriptions of severity categories and photographic examples of
mild, moderate, and severe keratitis. Co-investigators masked to treat-
ment group confirmed categorization by reviewing digital images of
representative eyes infected with different fungal strains. A grade of 0
to 4 was assigned for three criteria (area of opacity, density of opacity,
and surface regularity) to yield a possible total score of 0 to 12. The
area of corneal opacification was graded 1 if the nontranslucent zone
was 25% of the cornea, 2 for 26% to 50% involvement, 3 for 51% to
75%, and 4 for 75%. The density of a visible corneal opacity was
graded 1 if a cloudy zone was barely detectable, 2 for an observable
haze obscuring iris details, 3 for a marked opacity blurring the iris, and
4 for an opaque leukoma obstructing view of the iris or pupil. Corneal
surface irregularity was scored 1 for a slightly distorted surface, 2 for
mild changes in corneal thickness, 3 for moderate ulceration, and 4 for
a descemetocele or perforation. A normal-appearing cornea received a
score of 0 in each category. A total score of 5 was categorized as mild
eye disease, 5 to 9 was considered moderate, and 9 was severe.
Three to five mice were used for each strain and at each concentration.
Score results at each day PI were compared by the Kruskal-Wallis
one-way analysis of variance.
Histology
Mice used for histologic examination were killed, and the globes were
enucleated 1 day PI. The eyes from C. albicans–infected and mock-
infected mice were formalin-fixed, paraffin-embedded, and sectioned
at a thickness of 8 m for histologic study. The sections were depar-
affinized and stained with periodic acid-Schiff (PAS; Sigma-Aldrich, St.
Louis, MO) or modified Grocott’s methenamine silver (GMS; Richard-
Allan Scientific, Kalamazoo, MI).
RESULTS
The doubling time during the exponential growth phase of
each strain was significantly faster (P  0.001) in YPD than in
SD-ura media (Table 1). In YPD, the doubling times for control
and mutant strains were similar to those of wild-type (P  0.6).
When strains were grown in SD-ura media, growth rates of
both parental controls were similar to those of wild-type (P 
0.2), whereas both rbt1/ mutants grew more slowly com-
pared with their respective controls, DAY286 (P  0.05) and
CAF2-1 (P  0.003). BCa11-3, the rbt4/ mutant, grew more
slowly than wild-type (P  0.02) but similar to its parental
control (P  0.2).
Keratitis severity scores induced by the three rbt mutants
were compared with their respective parental controls at a 105
CFU inoculum (Fig. 1). Tn7-rbt1 and its parental control
DAY286 had similar scores at each day (P  0.1). Compared
with CAF2-1, no significant difference was observed with
BCa7-4 (P  0.7) or BCa11-3 (P  0.2). At a 106 CFU inoculum
(Fig. 2) keratitis severity was similar for DAY286 relative to
SC5314 (P  0.4). Tn7-rbt1 scores remained similar to DAY286
at an inoculum of 106 CFU (P  0.4). BCa7-4 slowly decreased
in severity compared with CAF2-1. For the first 4 days after
inoculation, a significant difference was not found between
these two strains (P  0.1), but keratitis scores of BCa7-4 were
less than CAF2-1 (P  0.05) and had a threefold reduction by
the eighth day (P  0.02). BCa11-3 also differed from its
parental control at 106 CFU on the first day after inoculation,
and disease scores remained significantly lower throughout the
next week (P  0.04). At an inoculum dose of 106 CFU, BCa7-4
and Tn7-rbt1 produced similar disease scores as their parental
controls at each day (P  0.1).
The dose–response relationship between 105 CFU and 106
CFU inocula was also compared for each strain. Fungal keratitis
was generally more severe at 106 CFU compared with 105 CFU,
although the relative increase between the two concentrations
varied among yeast strains. Keratitis scores for CAF2-1 were as
much as eight times lower than SC5314 at 105 CFU but were
similar to those of SC5314 at 106 CFU. BCa7-4 and BCa11-3
mutants had increased relative severity for the first 4 days
between the two inocula, and this relative increase in scores
was higher than that for wild-type. Beyond 5 days PI, the
relative difference in scores from 105 CFU to 106 CFU for the
knockout mutants decreased.
Histologic examination of infected eyes harvested 1 day PI
revealed budding yeasts. Hyphal forms were present in the
TABLE 1. Genotype and Growth Rate of Candida albicans Strains
Strain Name Strain Type Genotype
Doubling Time  SD
ReferenceYPD (h) SD-ura (h)*
SC5314 ura3/ Wild-type 1.60  0.09 2.22  0.08 Gillum et al.13
DAY286 ura3/ ura3::imm434 his1::hisG pARG4::URA3::arg4::hisG, 1.61  0.08 2.31  0.06 Davis et al.12
ura3::imm434 his1::hisG arg4::hisG
CAF2-1 ura3/ ura3::imm434 1.56  0.06 2.34  0.10 Fonzi and Irwin14
URA3
Tn7-rbt1 rbt1/ ura3::imm434 his1::hisG arg4::hisG rbt1::URA3 1.65  0.11 2.51  0.11† Davis et al.12
ura3/ ura3::imm434 his1::hisG arg4::hisG rbt1::ARG4
BCa7-4 rbt1/ ura3::imm434 rbt1::hisG-URA3-hisG 1.62  0.06 2.72  0.03† Braun et al.8
ura3/ ura3::imm434 rbt1::hisG
BCa11-3 rbt4/ ura3::imm434 rbt4::hisG-URA3-hisG 1.61  0.11 2.43  0.05 Braun et al.8
ura3/ ura3::imm434 rbt4::hisG
SD, standard deviation; YPD, yeast peptone dextrose medium; SD-ura, synthetic dextrose without uracil medium.
* For each fungal strain, in vitro growth in SD-ura medium was significantly slower (P  0.001) than in YPD medium.
† Strains that grew significantly more slowly (P  0.05) in SD-ura medium than the respective parental control.
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cornea for strains SC5314 (Fig. 3A), Tn7-rbt1, and BCa7-4. Both
parental control strains (DAY286 and CAF2-1) produced similar
fungal morphology and invasion as did the wild-type. Some
pseudohyphae were seen in BCa11-3-infected animals but were
limited to the superficial cornea (Fig. 3B). Neutrophilic infiltra-
tion and stromal thickening were prominent in corneas in-
fected with control and rbt1-deficient strains, whereas the
rbt4-deficient strain induced minimal corneal inflammation.
Mock-infected eyes did not show signs of infection or inflam-
mation but did have microscopic wounding changes from the
scarification procedure.
DISCUSSION
The emerging pathogenomics of C. albicans enables the iden-
tification of fungus-specific genes contributing to infection.15
Virulence factors are becoming known for disseminated and
mucocutaneous candidiasis,16 but few studies have examined
the molecular pathogenesis of fungal ocular infection. Re-
cently, homozygous mutants for Tup1p-regulated genes rbt1
and rbt4 were shown to attenuate virulence in a mouse model
of systemic candidiasis and in a rabbit model of C. albicans
keratitis.8 We examined these fungal rbt1 and rbt4 mutants in
FIGURE 1. Mean mouse keratitis scores
after inoculation with 105 CFU C. al-
bicans. Each yeast strain was inocu-
lated onto scarified corneas of
BALB/c mice at day 0 and monitored
for 8 days. Each day, the mouse eyes
were scored for the area, density,
and depth of ulcerative keratitis.
SC5314 is a wild-type yeast strain.
DAY286 is the mutant control for the
Tn7-rbt1 strain, and CAF2-1 is the
parental control for BCa7-4 and
BCa11-3. All mock-inoculated eyes
had a zero score for each time point.
FIGURE 2. Mean mouse keratitis scores
after inoculation with 106 CFU C. al-
bicans. Corneas were scarified and
inoculated on day 0. Eyes were
scored daily for 8 days.
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a mouse keratitis model and also studied a transposon-induced
rbt1 homozygous mutant.
C. albicans strains lacking rbt1 had disease severity similar
to that of parental controls at a lower fungal inoculum, sug-
gesting that this gene may not be an important determinant of
pathogenicity in murine corneal infection. At a higher fungal
inoculum we confirmed that a rbt1 knockout mutant had
partial attenuation for producing corneal disease but found
that a rbt1-deficient transposon mutant remained virulent. A
fungal strain deficient in rbt4 had significantly less severe
corneal infection at both inoculum concentrations and showed
partial attenuation in virulence. Histopathologically, the
rbt4/ strain also appeared relatively avirulent.
These findings suggest that the rbt4 gene of C. albicans
contributes to the pathogenesis of posttraumatic corneal infec-
tion. The rbt4 gene codes for a hyphally expressed, secreted
protein that is hypothesized to damage host cells.8 Rbt4 is
induced in the presence of serum and by depletion of the tup1
gene product.8 The link between rbt4 and fungal filamentation
complements our previous findings that hyphal morphogene-
sis plays a key role in the early events of fungal keratitis after
exposure to C. albicans.17
A secondary effect apparently modulated keratitis severity
produced by the knockout and parental constructs used in this
study, and differences in fungal genotypes could explain why
rbt1-deficient strains varied in relative disease severity at two
inoculum concentrations. One parental strain produced kera-
titis similar to wild-type at both inocula, whereas the other was
similar to wild-type only at the higher inoculum. Both strains
were derived from the wild-type isolate by using a technique
that makes strains heterozygous for the ura3 gene.14 The level
of ura3 gene activity does not influence the process of germ
tube formation but does lower the growth rate.18 Furthermore,
auxotrophic C. albicans strains have a lower level of pathoge-
nicity in mice, depending on the location of the ura3 gene.19
Our in vitro assay for proliferation kinetics confirmed slower
growth in uracil-deficient medium. Decreased gene expression
and reduced growth rate may lessen virulence in an in vivo
model when relatively low concentrations of these strains are
used.
An additional finding of this study was the dose–response
relationship of experimental C. albicans keratitis. At a lower
inoculum, the CAF2-1 control did not produce keratitis as
severe as the wild-type, SC5314. However, at a higher inocu-
lum, CAF2-1 caused disease similar in severity to that caused by
SC5314. Our results demonstrate the importance of the fungal
inoculating dose when evaluating disease severity.
Keratitis models offer a graded and nonlethal outcome for
dissecting fungal virulence pathways.20,21 The use of mutant
microbial genotypes is a valuable tool for providing insight into
the molecular pathogenesis of microbial infection of the cor-
nea. Because virulence factors may differ by infection site,
tissue-specific studies are needed to understand the mecha-
nisms of ocular fungal infections.
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